Quality & Innovation
This Belgian company has a history of pioneering rapid tests for use by microbiologists.
One of the the first companies to commercialise rapid tests for enteric viruses Coris RESIST products are the first lateral flow assays for the detection of antibiotic resistance mechanisms. whilst TRAPIST combines both PCR and immunoassay for rapid detection of organism and resistance mechanism from positive blood cultures.
Detecting micro-organisms - simply and reliably
Lateral flow immunochroma -tographic assays, are simple devices intended to detect the presence (or absence) of a target analyte in sample (matrix) without the need for specialized and costly equipment,
Ease of use and unambiguous reading of results are key requirements met by Coris BioConcept's tests.
Engagement in a total quality assurance programme - ISO 13485 - has reinforced innovation. All products are CE marked..
Patented in 2016 (WO 2016162564 A1) the Coris RESIST range are the first immunochromatography tests for carbapenemases.
They give results from culture in 15 minutes with sensitivity and specificity matching leading molecular systems
RESIST-4 O.K.N.V. K-Set launched in February 2018 adds VIM to the successful RESIST-3 O.K.N. kit. The kit covers over 98% of carbapenemases according to the PHE AMRHAI data updated October 2016
RESIST-3 O.K.N. K-Set launched in November 2016 brings together OXA-48 & KPC K-sets and adds NDM to produce a product that covers 95% of isolated .carbapenemases in the UK.
OXA-48 K-SeT was launched at ECCMID 2015 with presentations that support its efficacy. Subsequent UK evaluations have confirmed 100% sensitivity and specificity
KPC K-SeT was launched in August 2015, U.K & European evaluations confirm 100% sensitivity and specificity
Validation and a prospective study confirm 100% sensitivity and specificity.of RESIST-3 O.K.N.
Further investment in R& D supplemented by LONGITUDE prize funds ensures the RESIST range will continue to develop.
TRAPIST V6 is a fully automated instrument that performs multiplex diagnostic testings.
It is intended to be used in clinical laboratories for fast and easy multiplex diagnostics with disposable microfluidic chips.
Results are available within an hour. The platform enables a wide range of molecular assays as well as immunoassays.
Coris BioConcept’s lab-on-a-chip is a disposable device that combines multiplex PCR amplification and detection by hybridization on a membrane in a microfluidic environment.
Used in conjunction with the Trapist V6 automated system, the disposable microfluidic chip supports all the steps of a rapid, specific and sensitive multiplex diagnostic from a single DNA sample preparation.
DNA sample and reagents are introduced into the chip by a simple and convenient procedure before being automatically processed by the Trapist V6 system.
The entire chip is airtight, preventing carry-over contamination with amplified DNA.